186 related articles for article (PubMed ID: 33174078)
41. Percutaneous renal cryoablation in obese and morbidly obese patients.
Schmit GD; Thompson RH; Boorjian SA; McDonald RJ; Kurup AN; Weisbrod AJ; Kor DJ; Callstrom MR; Atwell TD
Urology; 2013 Sep; 82(3):636-41. PubMed ID: 23890665
[TBL] [Abstract][Full Text] [Related]
42. Safety and Oncologic Outcomes of Magnetic Resonance Imaging-Guided Cryoablation of Renal Cell Carcinoma: A 10-Year Single-Center Experience.
Cazzato RL; De Marini P; Leonard-Lorant I; Leclerc L; Auloge P; Tricard T; Dalili D; Garnon J; Lang H; Gangi A
Invest Radiol; 2021 Mar; 56(3):153-162. PubMed ID: 32897930
[TBL] [Abstract][Full Text] [Related]
43. Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery.
Morgan MA; Roberts NR; Pino LA; Trabulsi EJ; Brown DB; Gomella LG; Lallas CD
Can J Urol; 2013 Oct; 20(5):6933-7. PubMed ID: 24128832
[TBL] [Abstract][Full Text] [Related]
44. Cryoablation of Bone Metastases from Renal Cell Carcinoma for Local Tumor Control.
Gardner CS; Ensor JE; Ahrar K; Huang SY; Sabir SH; Tannir NM; Lewis VO; Tam AL
J Bone Joint Surg Am; 2017 Nov; 99(22):1916-1926. PubMed ID: 29135665
[TBL] [Abstract][Full Text] [Related]
45. Percutaneous cryoablation for renal cell carcinoma using ultrasound-guided targeting and computed tomography-guided ice-ball monitoring: radiation dose and short-term outcomes.
Kim DK; Won JY; Park SY
Acta Radiol; 2019 Jun; 60(6):798-804. PubMed ID: 30149751
[TBL] [Abstract][Full Text] [Related]
46. Cryoablation of renal cell carcinoma for patients with stage 4 or 5 non-dialysis chronic kidney disease.
Gobara H; Nakatsuka A; Shimizu K; Yamanaka T; Matsui Y; Iguchi T; Hiraki T; Yamakado K
Jpn J Radiol; 2019 Jun; 37(6):481-486. PubMed ID: 30941617
[TBL] [Abstract][Full Text] [Related]
47. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses.
Hinshaw JL; Shadid AM; Nakada SY; Hedican SP; Winter TC; Lee FT
AJR Am J Roentgenol; 2008 Oct; 191(4):1159-68. PubMed ID: 18806159
[TBL] [Abstract][Full Text] [Related]
48. Laparoscopic cryoablation for renal cell carcinoma: 100-Month oncologic outcomes. Caputo PA, Ramirez D, Zargar H, Akca O, Andrade HS, O'Malley C, Remer EM, Kaouk JH. J Urol. 2015 Oct;194(4):892-896. [Epub 2015 April 23]. doi: 10.1016/j.juro.2015.03.128.
Meng M
Urol Oncol; 2017 May; 35(5):311-312. PubMed ID: 28359745
[TBL] [Abstract][Full Text] [Related]
49. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience.
Tanagho YS; Bhayani SB; Kim EH; Figenshau RS
J Endourol; 2013 Dec; 27(12):1477-86. PubMed ID: 24283518
[TBL] [Abstract][Full Text] [Related]
50. First Prize (tie): Laparoscopic renal cryoablation: efficacy and complications for larger renal masses.
Lehman DS; Hruby GW; Phillips CK; McKiernan JM; Benson MC; Landman J
J Endourol; 2008 Jun; 22(6):1123-7. PubMed ID: 18484888
[TBL] [Abstract][Full Text] [Related]
51. Prospective analysis of the safety and efficacy of percutaneous cryoablation for pT1NxMx biopsy-proven renal cell carcinoma.
Rodriguez R; Cizman Z; Hong K; Koliatsos A; Georgiades C
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):573-8. PubMed ID: 20628879
[TBL] [Abstract][Full Text] [Related]
52. Percutaneous renal cryoablation: experience treating 115 tumors.
Atwell TD; Farrell MA; Leibovich BC; Callstrom MR; Chow GK; Blute ML; Charboneau JW
J Urol; 2008 Jun; 179(6):2136-40; discussion 2140-1. PubMed ID: 18423719
[TBL] [Abstract][Full Text] [Related]
53. Renal cryoablation combined with prior transcatheter arterial embolization in non-dialysis patients with stage 4 or 5 chronic kidney disease: a retrospective study.
Umakoshi N; Iguchi T; Matsui Y; Tomita K; Uka M; Kawabata T; Munetomo K; Nagata S; Gobara H; Araki M; Hiraki T
Jpn J Radiol; 2023 Sep; 41(9):1007-1014. PubMed ID: 37002430
[TBL] [Abstract][Full Text] [Related]
54. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
[TBL] [Abstract][Full Text] [Related]
55. Laparoscopic renal cryoablation: 8-year, single surgeon outcomes.
Aron M; Kamoi K; Remer E; Berger A; Desai M; Gill I
J Urol; 2010 Mar; 183(3):889-95. PubMed ID: 20089263
[TBL] [Abstract][Full Text] [Related]
56. Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation.
Beksac AT; Rivera-Sanfeliz G; Dufour CA; Nseyo U; Hamilton Z; Berquist SW; Hassan AE; Raheem OA; Wang S; Wake RW; Gold RE; Derweesh IH
World J Urol; 2017 Apr; 35(4):633-640. PubMed ID: 27484204
[TBL] [Abstract][Full Text] [Related]
57. Renal cryoablation of small renal masses: a Korea University experience.
Kim HK; Pyun JH; Kim JY; Kim SB; Cho S; Kang SG; Lee JG; Kim JJ; Cheon J; Kang SH
Korean J Urol; 2015 Feb; 56(2):117-24. PubMed ID: 25685298
[TBL] [Abstract][Full Text] [Related]
58. CT-Guided Percutaneous Cryoablation in Renal Cell Carcinoma: Factors Affecting Local Tumor Control.
Yamanaka T; Yamakado K; Yamada T; Fujimori M; Takaki H; Nakatsuka A; Sakuma H; Sugimura Y
J Vasc Interv Radiol; 2015 Aug; 26(8):1147-53. PubMed ID: 26123809
[TBL] [Abstract][Full Text] [Related]
59. Safety and Efficacy of Retrograde Pyeloperfusion for Ureteral Protection during Renal Tumor Cryoablation.
Marion JT; Schmitz JJ; Schmit GD; Kurup AN; Welch BT; Pasternak JJ; Boorjian SA; Leibovich BC; Atwell TD; Thompson RH
J Vasc Interv Radiol; 2020 Aug; 31(8):1249-1255. PubMed ID: 32457011
[TBL] [Abstract][Full Text] [Related]
60. Percutaneous cryoablation of masses in a solitary kidney.
Weisbrod AJ; Atwell TD; Frank I; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
AJR Am J Roentgenol; 2010 Jun; 194(6):1620-5. PubMed ID: 20489104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
